Another Immuno-Oncology Company, Another $90+ Million IPO

Harpoon Therapeutics announced that it will raise up to $93 million in its IPO. The company is offering 5,400,000 shares and is granting underwriters the option to purchase up to an additional 810,000 shares. The shares expected offering price is $13 to $15. Harpoon has applied to list our common stock on the Nasdaq Global Select Market under the trading symbol “HARP.”